Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
Qiuxian Zheng, Qin Yang, Jiaming Zhou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
Deguo Zhang, Da Man, Jiahua Lu, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 73
Multi-Omic Analyses of the m5C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
Chen Xue, Yalei Zhao, Ganglei Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 46
METTLing in Stem Cell and Cancer Biology
John G. Tooley, James Catlin, Christine E. Schaner Tooley
Stem Cell Reviews and Reports (2022) Vol. 19, Iss. 1, pp. 76-91
Closed Access | Times Cited: 30
Integrating bulk RNA-seq and scRNA-seq data to explore diverse cell death patterns and develop a programmed cell death-related relapse prediction model in pediatric B-ALL
Yaxin Luo, Lin Tan, Can Meng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Revealing Putative Causal Genes by Establishing the Causality Between Different Lymphomas and Immune Cells
Jingxuan Lian, Xinghong Zhang, Wenjie Chen, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 9
Open Access
Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers
Johnathan Abou‐Fadel, Victoria Reid, Alexander Le, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1012-1012
Open Access | Times Cited: 7
Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor
Hao Chen, Jinghua Wang, Ruijie Zeng, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 16
METTL9 derived circular RNA circ-METTL9 sponges miR-551b-5p to accelerate colorectal cancer progression by upregulating CDK6
Ming Li, Zheng Zhi, Xuan Jiang, et al.
Carcinogenesis (2023) Vol. 44, Iss. 6, pp. 463-475
Closed Access | Times Cited: 7
A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
Yongwei Chen, Yanyun Zhu, Yuanmei Dong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology
Dingxue Hu, Ziteng Zhang, Xiaoyi Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1
Xingnan Zhang, Chenhao Hu, Shengqiao Sun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma
Xiaoyan Zhang, Zhenxing Wen, Qi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
Zhihui Wang, Peihao Wen, Bowen Hu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma
Yinghui Zhu, Dezhi Shan, Lianyi Guo, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 1919-1931
Open Access | Times Cited: 3
DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma
Markia A. Smith, Sarah C. Van Alsten, Andrea Walens, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4282-4282
Open Access | Times Cited: 3
Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA Risk Signature in Hepatocellular Carcinoma
Haoyu Wang, Shangshang Hu, Junjie Nie, et al.
Analytical Cellular Pathology (2023) Vol. 2023, pp. 1-31
Open Access | Times Cited: 1
Biomarkers for Diagnosing and Treating Fetal Growth Restriction
Mengyao Wu, Junyu He, Yetao Chen, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 28, pp. 4461-4478
Closed Access | Times Cited: 1
Transcriptomic Analysis Reveals the Effects of miR-122 Overexpression in the Liver of Qingyuan Partridge Chickens
Xiaolu Luo, Jiahang Zhang, Jiancheng Guo, et al.
Animals (2024) Vol. 14, Iss. 14, pp. 2132-2132
Open Access
Revealing putative causal genes by establishing the causality between different lymphomas and immune cells
Jingxuan Lian, Xinghong Zhang, Wenjie Chen, et al.
Research Square (Research Square) (2024)
Open Access
Genetic association of tertiary lymphoid structure-related gene signatures with HCC based on Mendelian randomization and machine learning and construction of prognosis model
Pu Lei, Xiaoyan Zhang, Pu Cheng, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113594-113594
Open Access
TP53I11 Functions Downstream of Multiple MicroRNAs to Increase ER Calcium Levels and Inhibits Cancer Cell Proliferation
Yiping Wang, Shuai Zhang, Jie Bing, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 31-31
Open Access
Identification of Candidate Antigens and Immune Subtypes in Colon Cancer for mRNA Vaccine Development
Huolun Feng, Dandan Zhu, Jiabin Zheng, et al.
Advanced Therapeutics (2022) Vol. 5, Iss. 7
Closed Access | Times Cited: 1
Differential expression of key CmPn members distinguishes histological and immune subtypes of hepatic cancers
Johnathan Abou-Fade, Victoria Reid, Alexander Le, et al.
(2022)
Open Access | Times Cited: 1
Page 1

Scroll to top